Close Menu

The Scan

In Genome Research this week: approach to isolate viral genomes from metagenomic sequence collections, regulatory shifts in individuals with autism spectrum disorder, and more.

Tracing and Diving In

BBC News reports on a sequencing effort to track SARS-CoV-2 infections and uncover any co-infections.

Discover magazine writes that any resurrected mammoths might not really reflect how mammoths used to be.

Two Other Ways

Two publishers are testing new approaches to open access, according to Science.

In PNAS this week: role for MEN1 in pancreatic stress response, analysis of B immune cell response to yellow fever vaccine, and more.

According to the Seattle Times, the Bill & Melinda Gates Foundation is to enable home testing kits for SARS-CoV-2 to the Seattle area.

USA Today reports the Department of Justice issued a final rule that will enable the wider collection of DNA from individuals in federal immigration custody.

For Quick Diagnoses

The Deseret News reports that a rapid DNA sequencing project to diagnose sick infants has begun in Utah.

In PLOS this week: genomic epidemiological features of dengue virus in Guangdong, analysis of ancient plaque give insight into past diets, and more.

Ready to Run Tests

NPR reports that a Seattle lab is ready to run hundreds or even thousands of tests for SARS-CoV-2.

Before It Got Going

The Sydney Morning Herald reports that scientists were able to stop a Klebsiella outbreak before it took hold through sequencing.

A survey of Finnish dog owner finds many dogs have problematic behaviors that could have genetic ties, according to Scientific American.

In Science this week: single-cell RNA sequencing approach to study mRNA synthesis and degradation rates, atlas of protein-coding genes in human, pig, and mouse brains, and more.

The US House of Representatives has passed an emergency funding bill to address the COVID-19 outbreak, the New York Times reports.

The Associated Press says the Mississippi legislature is seeking to prohibit abortions sought due to genetic abnormalities, among other grounds.

In Nature this week: hybridization and introgression affected genetic diversity of Dutch elm disease, genetic and phenotypic landscape of mitochondria in a Japanese population, and more.

Entry Denied

Politico reports that a Food and Drug Administration official was not allowed to enter a Centers for Disease Control and Prevention campus, possibly due to a scheduling mix-up.

CRISPR for Blindness

According to the Associated Press, a patient has undergone gene editing to treat an inherited form of blindness.

Sharing It All

The Wall Street Journal looks into why some people who learn family secrets through genetic testing share that information publicly.

In Genome Biology this week: functional analysis of cancer drug resistance genes, transcriptome-wide association study of breast cancer, and more.

A trio of Senators were unimpressed with the lack of detail Google provided them regarding Project Nightingale, and they want answers.

Voters in Maine will have the opportunity to decide whether a law that eliminates religious and philosophical exemptions for childhood vaccines can go ahead.

Board Backing

The leader of MeTooSTEM has received the backing of the organization's executive board despite resignations and accusations of bullying.

In PNAS this week: 10-SNP polygenic risk score for papillary thyroid cancer performs as well as a larger one, loss-of-function mutation affecting voltage-gated sodium channel, and more.

The researchers explained why the virus was given the SARS-CoV-2 name and why it is not considered a new species.


Master's and doctoral students in the UK call on funding groups to extend their grants for the duration of the disruption caused by the COVID-19 outbreak, the Guardian reports.

Squid can make edits to their RNA within the cytoplasm of their axons, Science News reports.

The Chan Zuckerberg Initiative is putting $25 million toward COVID-19 treatment research, according to the Verge.

In Science this week: researchers engineer version of Cas9 that is nearly PAM-less, and more.